| Charles V Touey, MD | |
|
1597 Medical Dr, Pottstown, PA 19464-3224 | |
| (610) 326-6732 | |
| (610) 326-9652 |
| Full Name | Charles V Touey |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 31 Years |
| Location | 1597 Medical Dr, Pottstown, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295735934 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | MD058396L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Phoenixville Hospital | Phoenixville, PA | Hospital |
| Pottstown Hospital | Pottstown, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Regional Womens Health Group Llc | 2961316328 | 334 |
News Archive
A study by NPS in collaboration with the University of Melbourne —published today in the Medical Journal of Australia — has provided new insights into how people use medicines on a daily basis and highlights that the use of multiple medicines in older Australians is common and more complex than previously thought.
Aeris Therapeutics, LLC announced that the U.S. Patent and Trademark Office has issued a patent covering the use of cross-linked polymers administered into the lung to reduce lung volume for the treatment of emphysema.
The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) is to establish 20 Collaborative Research Centres (CRCs) by 1 July 2012. This decision was taken by the Grants Committee at its spring session in Bonn. The new CRCs will receive funding totalling 176 million euros (including a 20 percent programme allowance for indirect project costs) for the initial 4-year funding period.
Many patients with first-episode psychosis receive medications that do not comply with recommended guidelines for first-episode treatment, researchers have found. Current guidelines emphasize low doses of antipsychotic drugs and strategies for minimizing the side effects that might contribute to patients stopping their medication.
› Verified 5 days ago
| Entity Name | Community Health And Dental Care Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295994341 PECOS PAC ID: 5395804827 Enrollment ID: O20081112000554 |
News Archive
A study by NPS in collaboration with the University of Melbourne —published today in the Medical Journal of Australia — has provided new insights into how people use medicines on a daily basis and highlights that the use of multiple medicines in older Australians is common and more complex than previously thought.
Aeris Therapeutics, LLC announced that the U.S. Patent and Trademark Office has issued a patent covering the use of cross-linked polymers administered into the lung to reduce lung volume for the treatment of emphysema.
The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) is to establish 20 Collaborative Research Centres (CRCs) by 1 July 2012. This decision was taken by the Grants Committee at its spring session in Bonn. The new CRCs will receive funding totalling 176 million euros (including a 20 percent programme allowance for indirect project costs) for the initial 4-year funding period.
Many patients with first-episode psychosis receive medications that do not comply with recommended guidelines for first-episode treatment, researchers have found. Current guidelines emphasize low doses of antipsychotic drugs and strategies for minimizing the side effects that might contribute to patients stopping their medication.
› Verified 5 days ago
| Entity Name | Regional Womens Health Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750880118 PECOS PAC ID: 2961316328 Enrollment ID: O20180611002120 |
News Archive
A study by NPS in collaboration with the University of Melbourne —published today in the Medical Journal of Australia — has provided new insights into how people use medicines on a daily basis and highlights that the use of multiple medicines in older Australians is common and more complex than previously thought.
Aeris Therapeutics, LLC announced that the U.S. Patent and Trademark Office has issued a patent covering the use of cross-linked polymers administered into the lung to reduce lung volume for the treatment of emphysema.
The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) is to establish 20 Collaborative Research Centres (CRCs) by 1 July 2012. This decision was taken by the Grants Committee at its spring session in Bonn. The new CRCs will receive funding totalling 176 million euros (including a 20 percent programme allowance for indirect project costs) for the initial 4-year funding period.
Many patients with first-episode psychosis receive medications that do not comply with recommended guidelines for first-episode treatment, researchers have found. Current guidelines emphasize low doses of antipsychotic drugs and strategies for minimizing the side effects that might contribute to patients stopping their medication.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Charles V Touey, MD Po Box 22581, New York, NY 10087-2581 Ph: (610) 482-4795 | Charles V Touey, MD 1597 Medical Dr, Pottstown, PA 19464-3224 Ph: (610) 326-6732 |
News Archive
A study by NPS in collaboration with the University of Melbourne —published today in the Medical Journal of Australia — has provided new insights into how people use medicines on a daily basis and highlights that the use of multiple medicines in older Australians is common and more complex than previously thought.
Aeris Therapeutics, LLC announced that the U.S. Patent and Trademark Office has issued a patent covering the use of cross-linked polymers administered into the lung to reduce lung volume for the treatment of emphysema.
The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) is to establish 20 Collaborative Research Centres (CRCs) by 1 July 2012. This decision was taken by the Grants Committee at its spring session in Bonn. The new CRCs will receive funding totalling 176 million euros (including a 20 percent programme allowance for indirect project costs) for the initial 4-year funding period.
Many patients with first-episode psychosis receive medications that do not comply with recommended guidelines for first-episode treatment, researchers have found. Current guidelines emphasize low doses of antipsychotic drugs and strategies for minimizing the side effects that might contribute to patients stopping their medication.
› Verified 5 days ago
Yardlie Toussaint-foster, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1590 Medical Dr Ste A, Pottstown, PA 19464 Phone: 610-326-7172 Fax: 610-326-0974 | |
Lee S Zelley, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1600 E High St, Pottstown, PA 19464 Phone: 610-327-7000 Fax: 610-327-7432 | |
Elisa K Ross, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1597 Medical Dr, Pottstown, PA 19464 Phone: 610-326-6732 | |
Robert N Neilson, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1590 Medical Dr, Suite A, Pottstown, PA 19464 Phone: 610-327-7673 | |
Dr. Jessica Nancy Williams, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1610 Medical Dr, Suite 105, Pottstown, PA 19464 Phone: 484-925-0500 Fax: 610-432-0545 | |
Dr. Gabriella Pugliese, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1610 Medical Dr Ste 105, Pottstown, PA 19464 Phone: 484-925-0500 Fax: 610-432-0545 |